Lv1
10 积分 2024-12-30 加入
Abstract 3625: Urban-rural and racial disparities in the utilization of immune checkpoint inhibitor (ICI) treatments for non-small cell lung cancer (NSCLC)
1天前
求助中
Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis
21天前
已完结
Association of the PDCD5 Locus With Lung Cancer Risk and Prognosis in Smokers
1个月前
已完结
Programmed cell death protein 5 inhibits hepatocellular carcinoma progression by inducing pyroptosis through regulation of TGF-β/Smad2/3/Snail pathway
1个月前
已完结
Response to: Practical methods for incorporating summary time-to-event data into meta-analysis
7个月前
已完结
Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study
7个月前
已完结
FDA approval summary: fam-trastuzumab deruxtecan-nxki for unresectable or metastatic non-small cell lung cancer with activating HER2 mutations
7个月前
已完结
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
7个月前
已完结
Comparison between immunotherapy efficacy in early non-small cell lung cancer and advanced non-small cell lung cancer: a systematic review
9个月前
已完结
皖公网安备34019202002308
